Latest

Latest Cambridge News | Page 17

  • Latest Cambridge news stories and updates. What is happening today? All recent Cambridge news and developments. Live coverage and timeline of Cambridge. All you need to know about Cambridge.
Imfinzi plus chemotherapy recommended for approval in EU by CHMP as first immunotherapy regimen for advanced biliary tract cancer
Study sheds new light on benefits to children of water fluoridation
AstraZeneca expands global footprint in rare disease with availability of first Alexion rare disease therapy for patients
Imfinzi and Imjudo with chemotherapy approved in US for patients with metastatic non-small cell lung cancer
Farxiga improved symptom burden and health-related quality of life
AstraZeneca presents data at ASN Kidney Week 2022 reinforcing urgent need for early screening of chronic kidney disease and benefits
AstraZeneca funds R&D Postdoctoral Challenge finalists
Vaxzevria receives full Marketing Authorisation in EU for prevention of Covid
West Leederville Robbery Investigation
Cambridge Police community engagement day
Scientists warn of Earth’s unequivocal climate emergency
Awapuni on track for regional racing boost
Camizestrant significantly improved progression-free survival in advanced ER-positive breast cancer
Capivasertib Phase III trial met primary endpoints
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
Waikato Police investigating commercial incidents overnight
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
Identifying new pathways to treat cardiovascular disease
IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies
$4 million boost to help local governments reduce groundwater use
New recreation spaces for Trinity Drive Reserve
UK joins mission to search for origins of Universe
Artist’s sculptures inspired by wondrous world
First Australian Boat Race in three years comes to nail-biting end
North Queensland is pumped for major hydro milestone
Baffling ‘spiderweb’ star not ‘alien megastructure’
Larrakeyah Primary signs MOU with Leeds International School
University of Toronto ranked 18th in world – and second among North American public universities
Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022
Lithgow Library Garden Group
Latest on flood related road closures in Sydney at 6:30am
Latest on major road closures in Sydney due to flooding at 12:30pm
Novel Cell-Free Protein Crystallization Method to Advance Structural Biology
Two researchers awarded Mike Smith Student Prize for insightful essays
A1 Granny Flats Showcases Granny Flat Project in Cambridge Park
Former SCC Justice Rosalie Abella feted by her international peers at University of Toronto event
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1
Tezspire approved in Japan for treatment of severe asthma
PhD candidate first CDU student to receive prominent Chinese government award
2023 Breakthrough Prize in Life Sciences for Anthony Hyman and Clifford Brangwynne
Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis
Sydney faces Melbourne in first Australian Boat Race in three years
Backing innovative Tasmanian companies like Marinova to expand
Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
Tezspire approved in EU for treatment of severe asthma
Evusheld long-acting antibody combination approved in EU for treatment of Covid
Danicopan add-on to Ultomiris or Soliris met primary endpoint
Evusheld long-acting antibody combination recommended for approval in EU for treatment of Covid

© 2026 - The National Tribune Australia